[Protective effects of recombinant trichinella spiralis-53 000 protein combining with imipenem on polymicrobial

Abstract

Insights

The combination of recombinant Trichinella spiralis-53 000 protein (rTsP53 protein) and imipenem (IMP) significantly improved survival rates in septic mice. This combination therapy reduced pro-inflammatory cytokines and protected intestinal epithelial cells.

Area of Science:

  • Immunology and Infectious Diseases
  • Pharmacology and Therapeutics

Background:

  • Sepsis remains a leading cause of mortality, necessitating novel therapeutic strategies.
  • Polymicrobial sepsis models are crucial for evaluating broad-spectrum treatments.

Purpose of the Study:

  • To evaluate the protective effects of combining recombinant Trichinella spiralis-53 000 protein (rTsP53 protein) with imipenem (IMP) in a murine model of polymicrobial sepsis.
  • To elucidate the underlying mechanisms of this combined therapeutic approach.

Main Methods:

  • A polymicrobial sepsis model was established using cecal ligature and puncture (CLP) in male BALB/c mice.
  • Mice were treated with imipenem (IMP), rTsP53 protein, or a combination of both, alongside control groups.
  • Survival rates, bacterial load, serum cytokine levels (TNF-α, IL-6, IL-4, IL-10), and small intestinal mucosal ultrastructure were assessed.

Main Results:

  • The combination of IMP and rTsP53 protein significantly increased the 72-hour survival rate (85%) compared to CLP (20%), CLP+IMP (55%), and CLP+rTsP53 (25%) groups.
  • Combined therapy led to a rapid decline in bacterial load and modulated cytokine profiles, reducing pro-inflammatory markers (TNF-α, IL-6) while increasing anti-inflammatory markers (IL-4, IL-10).
  • Ultrastructural analysis revealed reduced damage to small intestinal epithelial cells in the combined treatment group.

Conclusions:

  • The combination of rTsP53 protein and IMP demonstrates significant protective effects in polymicrobial sepsis, enhancing survival.
  • This synergistic effect is attributed to the modulation of inflammatory responses and preservation of intestinal barrier integrity.
  • rTsP53 protein alone did not confer protection and augmented bacterial load, highlighting the importance of combined therapy.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.9K
Recombinant DNA01:09

Recombinant DNA

Overview
103.4K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.8K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
63.3K
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.2K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.9K